Antenatal manifestations of Smith-Lemli-Opitz (RSH) syndrome: A retrospective survey of 30 cases

被引:32
作者
Goldenberg, A
Wolf, C
Chevy, F
Benachi, A
Dumez, Y
Munnich, A
Cormier-Daire, V
机构
[1] Hop Necker Enfants Malad, Dept Med Genet, F-75043 Paris 15, France
[2] Hop St Antoine, Lab Mass Spectrometry, F-75571 Paris, France
[3] Hop Necker Enfants Malad, Dept Obstet, Paris, France
关键词
Smith-Lemli-Opitz syndrome; RSH syndrome; antenatal manifestations;
D O I
10.1002/ajmg.a.20448
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Smith-Lemli-Opitz (SLO) syndrome or RSH syndrome is an autosomal recessive multiple malformation, and mental retardation syndrome ascribed to 7-dehydrocholesterol reductase deficiency, and usually diagnosed in the early postnatal period. Reviewing a series of 30 cases of SLO, we have investigated the variable antenatal expression of the disorder. Intrauterine growth retardation (IUGR) was the most frequent detectable trait (20/30). IUGR was either isolated (9/20) or associated with at least one other anomaly (11/20), including nuchal edema, renal, cardiac, cerebral malformations, genital anomalies, or polydactyly. In this last group, 3/11 presented with multiple malformations (greater than or equal to3 anomalies). In 5/30 cases, isolated nuchal edema (3/30), and isolated cardiac (1/30) or renal malformations (1/30) were the only detectable anomalies. Ultrasound findings were considered normal in 5/30 cases and were abnormal in 25/30 cases (83%), but early detection of multiple malformations was rare (3/30, 10%). We suggest giving consideration to a more systematic sterol analysis when dealing with IUGR, especially when associated anomalies are detected. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:423 / 426
页数:4
相关论文
共 33 条
[1]   PRENATAL DETECTION OF THE CHOLESTEROL BIOSYNTHETIC DEFECT IN THE SMITH-LEMLI-OPITZ SYNDROME BY THE ANALYSIS OF AMNIOTIC LIQUID STEROLS [J].
ABUELO, DN ;
TINT, GS ;
KELLEY, R ;
BATTA, AK ;
SHEFER, S ;
SALEN, G .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 56 (03) :281-285
[2]  
Bick DP, 1999, PRENATAL DIAG, V19, P68, DOI 10.1002/(SICI)1097-0223(199901)19:1<68::AID-PD461>3.0.CO
[3]  
2-3
[4]  
Bradley LA, 1999, AM J MED GENET, V82, P355, DOI 10.1002/(SICI)1096-8628(19990212)82:4<355::AID-AJMG16>3.0.CO
[5]  
2-4
[6]   INCREASED FIRST-TRIMESTER NUCHAL TRANSLUCENCY AS A PRENATAL MANIFESTATION OF SMITH-LEMLI-OPITZ-SYNDROME [J].
HYETT, JA ;
CLAYTON, PT ;
MOSCOSO, G ;
NICOLAIDES, KH .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 58 (04) :374-376
[7]   ABNORMAL CHOLESTEROL-METABOLISM IN THE SMITH-LEMLI-OPITZ SYNDROME - REPORT OF CLINICAL AND BIOCHEMICAL FINDINGS IN 4 PATIENTS AND TREATMENT IN ONE PATIENT [J].
IRONS, M ;
ELIAS, ER ;
TINT, GS ;
SALEN, G ;
FRIEDEN, R ;
BUIE, TM ;
AMPOLA, M .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 50 (04) :347-352
[8]   DEFECTIVE CHOLESTEROL-BIOSYNTHESIS IN SMITH-LEMLI-OPTIZ SYNDROME [J].
IRONS, M ;
ELIAS, ER ;
SALEN, G ;
TINT, GS ;
BATTA, AK .
LANCET, 1993, 341 (8857) :1414-1414
[9]  
Irons MB, 1998, PRENATAL DIAG, V18, P369, DOI 10.1002/(SICI)1097-0223(199804)18:4<369::AID-PD373>3.3.CO
[10]  
2-T